NASDAQ: BCLI
Brainstorm Cell Therapeutics Revenue

Brainstorm Cell Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BCLI annual revenue was $0.0, with N/A growth year-over-year.

BCLI revenue history

Current Revenue
$0.0
Current Earnings
-$11.6M
Current Profit Margin
0%

Be the first to know when BCLI announces revenue.

BCLI Revenue History By Year

BCLI Yearly RevenueBCLI RevenueBCLI ChangeBCLI Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A
2016-12-31$0.00N/AN/A
2015-12-31$0.00N/AN/A
2014-12-31$0.00N/AN/A
2013-12-31$0.00N/AN/A
2012-12-31$0.00N/AN/A
2011-12-31$0.00N/AN/A
2010-12-31$0.00N/AN/A
2009-12-31$0.00N/AN/A
2008-12-31$0.00N/AN/A
2007-12-31$0.00N/AN/A
2006-12-31N/AN/AN/A

1 of 2

Brainstorm Cell Therapeutics Revenue FAQ

What was BCLI's revenue last quarter?

On Invalid Date, Brainstorm Cell Therapeutics (NASDAQ: BCLI) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Brainstorm Cell Therapeutics's revenue was $0.00.

What was Brainstorm Cell Therapeutics's revenue in 2024?

Brainstorm Cell Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Brainstorm Cell Therapeutics make in a day?

Based on Brainstorm Cell Therapeutics annual revenue for the past five years, BCLI makes an average of $0.00 per day.

What was Brainstorm Cell Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Brainstorm Cell Therapeutics's revenue has grown null year over year. Brainstorm Cell Therapeutics's revenue in the past year totaled $0.00.

How much does Brainstorm Cell Therapeutics make in a year?

Brainstorm Cell Therapeutics's revenue by year for the past five years is:
  • Brainstorm Cell Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Brainstorm Cell Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
  • Brainstorm Cell Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Brainstorm Cell Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
  • Brainstorm Cell Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.